Genetron Health Won First Place in the Bioscience List in the "Chinese Entrepreneur" Science and Technology Award

Release time:2019-07-09

On July 8th, the '19th Star of the Future Annual Meeting' organized by 'China Entrepreneur' unveiled the results of 'Top 100 Chinese Science and Technology Enterprises', Genetron Health was ranked 18th overall and 1st in science and technology, cancer gene detection list.


This is the 19th year that 'China Entrepreneur' has released the list on the Star of Future. Among the 378 extraordinary companies that have been on the list are Tencent, Baidu, Xiaomi, Jingdong, Meituan, Ant Financial, etc. The selection of winners of “Science and Technology Awards” lasted for 3 months. Among the over 500 companies that were nominated, they were shortlisted according to the three core indicators of scientific and technological strength, investment value and growth value, and finally selected 100 industry leaders with high recognition, hardcore innovation and good social image.


Zhenhong He, President of China Entrepreneur Magazine, spoke about three key factors on “hardcore innovation”. “They shall be, first of all, very cool and unique, the second is beyond tradition and represents the future; the third is the ability to form a market advantage in the digital age and can be transformed into products and revenues.” She also mentioned that “hardcore innovation” includes both hardcore technology innovation, business model innovation, organizational change, and management innovation, etc.


Genetron Health has always adhered to the philosophy of “Exploration, discovery, application and change”, and is committed to scientific research, transformation of results and clinical application of cancer precision medicine. In the past 5 years, it has 20 domestic patents and 4 international patents granted or pending.


More than 10 academic papers have been published in top international journals, and cooperation with more than hundreds of top medical institutions in China. It also has been established to serve tens of thousands of samples. Three IVD products have been approved by CFDA, and innovative technologies such as “Genetron One Step Amplicon Technology”, “Genetron Mutation Capsule Technology”, “Genetron Hepatocellular Carcinoma Screen” have been discovered and applied. In the future, we will continue to expand to the upstream and downstream of the industrial chain. The company will actively promote technological innovation in cancer early screening, work with  pharmaceutical companies in the field of cancer treatment, and gradually expand the business to the world. 'Hard core innovation' penetrates through the growth of Genetron Health and it will lead Genetron Health to the world.


COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
Genetron Health Genetron Health Management
COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
犀牛云提供云计算服务
Messages
  • *To
  • *Subject
  • *Name
  • *Tel
  • Work Unit
  • *Email
  • 详细说明:
  • Verification code:
Genetron Health Genetron Health Management